BYFAVO
NDC 71390-011, remimazolam besylate, injection, powder, lyophilized, for solution, from Acacia Pharma, Ltd..
- Product NDC
- 71390-011
- Status
- Listed
- Labeler
- Acacia Pharma, Ltd.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA212295
- DEA schedule
- CIV
curl https://api.healthcare.dev/v1/drugs/ndc/71390-011 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- REMIMAZOLAM BESYLATE2.5 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71390-011-11 | 71390001111 | 10 VIAL in 1 CARTON (71390-011-11) / 8 mL in 1 VIAL (71390-011-00) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4e1838f2-b999-41a7-a761-d94f09aa531f
Use it
Look up 71390-011 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71390-011 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71390-011. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.